Antifungal and Antileukemic Compounds from Cyanobacteria: Bioactivity, Biosynthesis, and Mechanism of Action

Total Page:16

File Type:pdf, Size:1020Kb

Antifungal and Antileukemic Compounds from Cyanobacteria: Bioactivity, Biosynthesis, and Mechanism of Action ANTIFUNGAL AND ANTILEUKEMIC COMPOUNDS FROM CYANOBACTERIA: BIOACTIVITY, BIOSYNTHESIS, AND MECHANISM OF ACTION Anu Humisto Department of Microbiology Faculty of Agriculture and Forestry University of Helsinki, Finland ACADEMIC DISSERTATION To be presented, with the permission of the Faculty of Agriculture and Forestry of the University of Helsinki, for public examination in Auditorium I at Info Centre Korona, Viikinkaari 11, on 23rd November 2018, at 12 o'clock noon. Helsinki 2018 Supervisors Professor Kaarina Sivonen Department of Microbiology University of Helsinki, Finland Professor Lars Herfindal Department of Clinical Science University of Bergen, Norway Docent Jouni Jokela Department of Microbiology University of Helsinki, Finland Reviewers Docent Päivi Tammela Division of Pharmaceutical Biosciences Faculty of Pharmacy University of Helsinki, Finland Professor Lena Gerwick Center for Marine Biotechnology and Biomedicine Scripps Institution of Oceanography University of California San Diego, USA Thesis evaluation committee Professor Per Saris Department of Microbiology University of Helsinki, Finland Academy Fellow Miia Mäkelä Department of Microbiology University of Helsinki, Finland Opponent Professor Jeanette H. Andersen Norwegian College of Fishery Science University of Tromsø, Norway Custos Professor Kaarina Sivonen Department of Microbiology University of Helsinki, Finland Dissertationes Schola Doctoralis Scientiae Circumiectalis, Alimentariae, Biologicae Cover: Lake Löytänejärvi (Pori, Finland), light micrograph of Nostoc sp. UHCC 0450, and transmission electron micrograph of MOLM-13 cell organelles. All figures by Anu Humisto. ISSN 2342-5423 (print) ISSN 2342-5431 (online) ISBN 978-951-51-4658-8 (paperback) ISBN 978-951-51-4659-5 (PDF) http://ethesis.helsinki.fi Unigrafia Helsinki 2018 Table of contents LIST OF ORIGINAL PUBLICATIONS .......................................................................... III LIST OF RELATED PUBLICATIONS ............................................................................ IV ABBREVIATIONS ..................................................................................................... V ABSTRACT ............................................................................................................. VI TIIVISTELMÄ ......................................................................................................... VII 1 INTRODUCTION .............................................................................................. 1 1.1 NATURAL PRODUCTS AND THEIR IMPORTANCE ........................................................ 1 1.2 CYANOBACTERIA AND THEIR NATURAL PRODUCTS .................................................... 2 1.3 BIOACTIVITY ..................................................................................................... 4 1.3.1 Anticancer activity ........................................................................................ 5 1.3.2 Antifungal activity ......................................................................................... 9 1.4 BIOSYNTHESIS ................................................................................................ 16 1.4.1 Polyketide synthesis ................................................................................... 17 1.4.2 Nonribosomal peptide synthesis and hybrid synthesis .............................. 18 1.5 MECHANISM OF ACTION ................................................................................... 19 2 STUDY AIMS ................................................................................................. 22 3 SUMMARY OF MATERIALS AND METHODS ................................................... 23 3.1 STRAINS AND CELL LINES USED IN THIS THESIS ........................................................ 23 3.2 SUMMARY OF METHODS .................................................................................. 23 4 SUMMARY OF RESULTS AND DISCUSSION .................................................... 25 4.1 BIOACTIVE CYANOBACTERIAL COMPOUNDS .......................................................... 25 4.1.1 Antileukemic activity (I) .............................................................................. 25 4.1.2 Antifungal or cytotoxic activity (II, IV) ........................................................ 26 4.1.3 Culture collections and screening (I–IV) ..................................................... 29 4.2 DISCOVERING BIOSYNTHESIS PATHWAYS (III) ........................................................ 30 4.3 ELUCIDATING MECHANISM OF ACTION (IV) .......................................................... 3 5 5 CONCLUSIONS AND FUTURE PROSPECTS ...................................................... 39 6 ACKNOWLEDGEMENTS ................................................................................. 41 7 REFERENCES ................................................................................................. 42 I II List of original publications This thesis is based on the following publications: I Humisto A, Herfindal L, Jokela J, Karkman A, Bjørnstad R, Choudhury RR, Sivonen K. 2016. Cyanobacteria as a source for novel anti-leukemic compounds. Current Pharmaceutical Biotechnology, 17(1):78–91. II Shishido TK, Humisto A, Jokela J, Liu L, Wahlsten M, Tamrakar A, Fewer DP, Permi P, Andreote APD, Fiore MF, Sivonen K. 2015. Antifungal compounds from cyanobacteria. Marine Drugs, 13(4):2124–2140. III Humisto A, Jokela J, Liu L, Wahlsten M, Wang H, Permi P, Machado JP, Antunes A, Fewer DP, Sivonen K. 2018. The swinholide biosynthesis gene cluster from a terrestrial cyanobacterium, Nostoc sp. strain UHCC 0450. Applied and Environmental Microbiology, 84(3):e02321-17. IV Humisto A, Jokela J, Teigen K, Wahlsten M, Permi P, Sivonen K, Herfindal L. 2018. Characterization of the membrane interaction of the antifungal and cytotoxic cyclic glycolipopeptide hassallidin. Submitted manuscript. The publications are referred to in the text by their roman numerals. Author's contribution I Anu Humisto participated in the design of the study, performed the experiments, participated in the data analysis, and wrote the first article draft. II Anu Humisto participated in the design of the study, performed part of the ex- periments, and participated in the writing of the manuscript. III Anu Humisto participated in the design of the study, performed the experiments, participated in the data analysis, and wrote the first article draft. IV Anu Humisto participated in the design of the study, performed the experiments, participated in the data analysis, and wrote the first article draft. III List of related publications V Pancrace C, Jokela J, Sassoon N, Ganneau C, Desnos-Ollivier M, Wahlsten M, Humisto A, Calteau A, Bay S, Fewer DP, Sivonen K, Gugger M. 2017. Rearranged biosynthetic gene cluster and synthesis of hassallidin E in Planktothrix serta PCC 8927. ACS Chemical Biology, 12(7):1796–1804. IV Abbreviations A Adenylation domain ACP Acyl carrier protein AML Acute myeloid leukemia AT Acyltransferase domain C Condensation domain cf. sp. Uncertainly defined species DH Dehydratase E Epimerization domain EC50 Half-maximal effective concentration ER Enoyl reductase HGT Horizontal gene transfer IC50 Half-maximal inhibitory concentration IPC-81 Rat acute myeloid leukemia cell line kb Kilo base pairs KS Ketosynthase KS0 Nonelongating ketosynthase KR Ketoreductase LC-MS Liquid chromatography mass spectrometry Mb Mega base pairs MIC Minimum inhibitory concentration MOA Mechanism of action MOLM-13 Human acute myeloid leukemia cell line MT Methyl transferase NMR Nuclear magnetic resonance NRK Normal rat kidney epithelial cell line NRPS Nonribosomal peptide synthetase OMT O-methyl transferase ORF Open reading frame OX Monooxygenase domain PCP Peptidyl carrier protein PKS Polyketide synthase PS Pyran synthase scp Scytophycin gene cluster sp. Species swi Swinholide gene cluster TE Thioesterase domain UHCC University of Helsinki Cyanobacteria Culture Collection V Abstract Nature is a treasury of bioactive natural products that are developed into pharmaceuticals, cosmetics and other industrial applications. Natural products have an impact on all of us, for instance, in the form of antibiotics. Most of the drugs sold today are natural products or their derivatives. However, the need for new natural products has not decreased but is ra- ther increasing. The incidences of certain diseases such as cancers are rising and resistance to treatment is a major problem. Especially prokaryotes and plants produce these intriguing natural products, which display several different bioactivities. Cyanobacteria are photosyn- thetic prokaryotes that belong to the most prolific sources of bioactive compounds. This study expands the knowledge of cyanobacterial natural products, including their activities, biosynthesis, and mechanisms of action. The University of Helsinki Cyanobacteria Culture Collection was utilized in this study. Cultured cyanobacteria were screened for an- tileukemic and antifungal activity using cell assays and disk diffusion analyses. Bioactive compounds were identified with spectrometric methods. The screenings revealed several bioactive hits, including antifungal, antileukemic and cytotoxic activities. Novel compound candidates and known compounds from new habitats or genera were found. In addition, novel variants of known compounds were identified. The results from screening were used to select cyanobacterial strains for whole ge- nome sequencing. Genomic analysis was used to
Recommended publications
  • Marine Natural Products: a Source of Novel Anticancer Drugs
    marine drugs Review Marine Natural Products: A Source of Novel Anticancer Drugs Shaden A. M. Khalifa 1,2, Nizar Elias 3, Mohamed A. Farag 4,5, Lei Chen 6, Aamer Saeed 7 , Mohamed-Elamir F. Hegazy 8,9, Moustafa S. Moustafa 10, Aida Abd El-Wahed 10, Saleh M. Al-Mousawi 10, Syed G. Musharraf 11, Fang-Rong Chang 12 , Arihiro Iwasaki 13 , Kiyotake Suenaga 13 , Muaaz Alajlani 14,15, Ulf Göransson 15 and Hesham R. El-Seedi 15,16,17,18,* 1 Clinical Research Centre, Karolinska University Hospital, Novum, 14157 Huddinge, Stockholm, Sweden 2 Department of Molecular Biosciences, the Wenner-Gren Institute, Stockholm University, SE 106 91 Stockholm, Sweden 3 Department of Laboratory Medicine, Faculty of Medicine, University of Kalamoon, P.O. Box 222 Dayr Atiyah, Syria 4 Pharmacognosy Department, College of Pharmacy, Cairo University, Kasr el Aini St., P.B. 11562 Cairo, Egypt 5 Department of Chemistry, School of Sciences & Engineering, The American University in Cairo, 11835 New Cairo, Egypt 6 College of Food Science, Fujian Agriculture and Forestry University, Fuzhou, Fujian 350002, China 7 Department of Chemitry, Quaid-i-Azam University, Islamabad 45320, Pakistan 8 Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Staudingerweg 5, 55128 Mainz, Germany 9 Chemistry of Medicinal Plants Department, National Research Centre, 33 El-Bohouth St., Dokki, 12622 Giza, Egypt 10 Department of Chemistry, Faculty of Science, University of Kuwait, 13060 Safat, Kuwait 11 H.E.J. Research Institute of Chemistry,
    [Show full text]
  • Algal Toxic Compounds and Their Aeroterrestrial, Airborne and Other Extremophilic Producers with Attention to Soil and Plant Contamination: a Review
    toxins Review Algal Toxic Compounds and Their Aeroterrestrial, Airborne and other Extremophilic Producers with Attention to Soil and Plant Contamination: A Review Georg G¨аrtner 1, Maya Stoyneva-G¨аrtner 2 and Blagoy Uzunov 2,* 1 Institut für Botanik der Universität Innsbruck, Sternwartestrasse 15, 6020 Innsbruck, Austria; [email protected] 2 Department of Botany, Faculty of Biology, Sofia University “St. Kliment Ohridski”, 8 blvd. Dragan Tsankov, 1164 Sofia, Bulgaria; mstoyneva@uni-sofia.bg * Correspondence: buzunov@uni-sofia.bg Abstract: The review summarizes the available knowledge on toxins and their producers from rather disparate algal assemblages of aeroterrestrial, airborne and other versatile extreme environments (hot springs, deserts, ice, snow, caves, etc.) and on phycotoxins as contaminants of emergent concern in soil and plants. There is a growing body of evidence that algal toxins and their producers occur in all general types of extreme habitats, and cyanobacteria/cyanoprokaryotes dominate in most of them. Altogether, 55 toxigenic algal genera (47 cyanoprokaryotes) were enlisted, and our analysis showed that besides the “standard” toxins, routinely known from different waterbodies (microcystins, nodularins, anatoxins, saxitoxins, cylindrospermopsins, BMAA, etc.), they can produce some specific toxic compounds. Whether the toxic biomolecules are related with the harsh conditions on which algae have to thrive and what is their functional role may be answered by future studies. Therefore, we outline the gaps in knowledge and provide ideas for further research, considering, from one side, Citation: G¨аrtner, G.; the health risk from phycotoxins on the background of the global warming and eutrophication and, ¨а Stoyneva-G rtner, M.; Uzunov, B.
    [Show full text]
  • Investigations on the Impact of Toxic Cyanobacteria on Fish : As
    INVESTIGATIONS ON THE IMPACT OF TOXIC CYANOBACTERIA ON FISH - AS EXEMPLIFIED BY THE COREGONIDS IN LAKE AMMERSEE - DISSERTATION Zur Erlangung des akademischen Grades des Doktors der Naturwissenschaften an der Universität Konstanz Fachbereich Biologie Vorgelegt von BERNHARD ERNST Tag der mündlichen Prüfung: 05. Nov. 2008 Referent: Prof. Dr. Daniel Dietrich Referent: Prof. Dr. Karl-Otto Rothhaupt Referent: Prof. Dr. Alexander Bürkle 2 »Erst seit gestern und nur für einen Tag auf diesem Planeten weilend, können wir nur hoffen, einen Blick auf das Wissen zu erhaschen, das wir vermutlich nie erlangen werden« Horace-Bénédict de Saussure (1740-1799) Pionier der modernen Alpenforschung & Wegbereiter des Alpinismus 3 ZUSAMMENFASSUNG Giftige Cyanobakterien beeinträchtigen Organismen verschiedenster Entwicklungsstufen und trophischer Ebenen. Besonders bedroht sind aquatische Organismen, weil sie von Cyanobakterien sehr vielfältig beeinflussbar sind und ihnen zudem oft nur sehr begrenzt ausweichen können. Zu den toxinreichsten Cyanobakterien gehören Arten der Gattung Planktothrix. Hierzu zählt auch die Burgunderblutalge Planktothrix rubescens, eine Cyanobakterienart die über die letzten Jahrzehnte im Besonderen in den Seen der Voralpenregionen zunehmend an Bedeutung gewonnen hat. An einigen dieser Voralpenseen treten seit dem Erstarken von P. rubescens existenzielle, fischereiwirtschaftliche Probleme auf, die wesentlich auf markante Wachstumseinbrüche bei den Coregonenbeständen (Coregonus sp.; i.e. Renken, Felchen, etc.) zurückzuführen sind. So auch
    [Show full text]
  • Degradation of Microcystins in a Gravity-Driven Ultra-Low Pressure
    Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2014 Structural characterization, bioactivity and biodegradation of cyanobacterial toxins Kohler, Esther Posted at the Zurich Open Repository and Archive, University of Zurich ZORA URL: https://doi.org/10.5167/uzh-105523 Dissertation Published Version Originally published at: Kohler, Esther. Structural characterization, bioactivity and biodegradation of cyanobacterial toxins. 2014, University of Zurich, Faculty of Science. STRUCTURAL CHARACTERIZATION, BIOACTIVITY AND BIODEGRADATION OF CYANOBACTERIAL TOXINS Dissertation zur Erlangung der naturwissenschaftlichen Doktorwürde (Dr. sc. nat.) vorgelegt der Mathematisch-naturwissenschaftlichen Fakultät der Universität Zürich von Esther Kohler von Schwaderloch AG Promotionskomitee Prof. Dr. Jakob Pernthaler (Vorsitz) Prof. Dr. Leo Eberl PD Dr. Judith F. Blom Zürich, 2015 Meiner Familie GLOSSARY Adda (2S,3S,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid AG 828A Aeruginosin 828A Ahp 3-amino-6-hydroxy-2-piperidone BMAA β-methyl-amino-L-alanine Choi 2-carboxy-6-hydroxyoctahydroindole CP 1020 Cyanopeptolin 1020 DNA Deoxyribonucleic acid DOPA Dihydroxyphenylalanine GC-MS Gas chromatography-mass spectrometry GDM Gravity-driven membrane filtration GSH Glutathione GST Glutathione-s-transferase (H)PLA (Hydroxyl)phenyllactic acid HPLC High-performance liquid chromatography IC50 Half maximal inhibitory concentration i.p. Intraperitoneal (injection) LC50 Median
    [Show full text]
  • Mass-Spectrometry Based Metabolomics to Decipher Strain Specific Microcystis Cyanopeptide Profiles
    MASS-SPECTROMETRY BASED METABOLOMICS TO DECIPHER STRAIN SPECIFIC MICROCYSTIS CYANOPEPTIDE PROFILES by Kimberlynn Pearl McDonald A thesis submitted to the Faculty of Graduate and Postdoctoral Affairs in partial fulfillment of the requirements for the degree of Master of Science in Chemistry with Specialization in Chemical and Environmental Toxicology Carleton University Ottawa, Ontario © 2020, Kimberlynn Pearl McDonald i. Abstract Over the last one hundred years, ecosystem changes have occurred as a result of human population growth, pollution, increased temperatures, and habitat degradation. A visible change is the increase in frequency and magnitude of toxic cyanobacterial blooms. Cyanobacterial blooms release mixtures of biologically active compounds into freshwater that negatively impact human and ecosystem health as well as having socioeconomic consequences. The factors that influence cyanobacterial growth and toxin production are broadly understood. However, cyanobacteria are a prolific source of structurally diverse and strain specific mixtures of biologically active compounds. Currently, the chemistry, toxicology, environmental concentrations, and risks posed to human and ecosystem health by most cyanobacterial secondary metabolites are unknown. Advances in mass spectrometry and metabolomic techniques can aid in comprehension of complex metabolomes. Here, the use of untargeted and semi-targeted mass spectrometry-based metabolomics is used to decipher the non-ribosomal peptide natural products (cyanopeptides) from five Microcystis strains. Cyanopeptides are grouped based on shared structural features, such as the incorporation of non-proteogenic amino acids or partial amino acid sequences that generate diagnostic product ions with the MS/MS of metabolites within the same cyanopeptide group. Global natural product society (GNPS) molecular networking and diagnostic fragmentation filtering (DFF) techniques utilize the similarity in product ion spectra to visualize all variants in the different cyanopeptide groups and the production by Microcystis strains.
    [Show full text]
  • UNIVERSITY of CALIFORNIA, SAN DIEGO Novel
    UNIVERSITY OF CALIFORNIA, SAN DIEGO Novel Biodiversity of Natural Products-producing Tropical Marine Cyanobacteria A Dissertation submitted in partial satisfaction of the requirement for the degree Doctor of Philosophy in Oceanography by Niclas Engene Committee in Charge: Professor William H. Gerwick, Chair Professor James W. Golden Professor Paul R. Jensen Professor Brian Palenik Professor Gregory W. Rouse Professor Jennifer E. Smith 2011 Copyright Niclas Engene, 2011 All rights reserved. The Dissertation of Niclas Engene is approved, and it is acceptable in quality and form for publication on microfilm and electronically: Chair University of California, San Diego 2011 iii DEDICATION This dissertation is dedicated to everyone that has been there when I have needed them the most. iv TABLE OF CONTENTS Signature Page …………………………………………………..……………………... iii Dedication ……………...………………………………………………………..….….. iv Table of Contents ………...…………………………………………………..…………. v List of Figures ……………………………………………………………………..…… ix List of Tables …………………………………………………………..…………..….. xii List of Abbreviations ………......……………………………………..………….…… xiv Acknowledgments ...…………………………………….……………………..…..… xvii Vita …………………………………………………………………………..……........ xx Abstract …………………………………………………………………………..….. xxiv Chapter I.Introduction ……………………..……………………………………..……… 1 Natural Products as Ancient Medicine ……….….…………………….…….……. 2 Marine Natural Products …………………….….………………….……….…….. 3 Cyanobacterial Natural Products …………………….….………………….……. 10 Current Perspective of the Taxonomic Distribution of
    [Show full text]
  • Cyanobacteria and Cyanotoxins: from Impacts on Aquatic Ecosystems and Human Health to Anticarcinogenic Effects
    Toxins 2013, 5, 1896-1917; doi:10.3390/toxins5101896 OPEN ACCESS toxins ISSN 2072-6651 www.mdpi.com/journal/toxins Review Cyanobacteria and Cyanotoxins: From Impacts on Aquatic Ecosystems and Human Health to Anticarcinogenic Effects Giliane Zanchett and Eduardo C. Oliveira-Filho * Universitary Center of Brasilia—UniCEUB—SEPN 707/907, Asa Norte, Brasília, CEP 70790-075, Brasília, Brazil; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +55-61-3388-9894. Received: 11 August 2013; in revised form: 15 October 2013 / Accepted: 17 October 2013 / Published: 23 October 2013 Abstract: Cyanobacteria or blue-green algae are among the pioneer organisms of planet Earth. They developed an efficient photosynthetic capacity and played a significant role in the evolution of the early atmosphere. Essential for the development and evolution of species, they proliferate easily in aquatic environments, primarily due to human activities. Eutrophic environments are conducive to the appearance of cyanobacterial blooms that not only affect water quality, but also produce highly toxic metabolites. Poisoning and serious chronic effects in humans, such as cancer, have been described. On the other hand, many cyanobacterial genera have been studied for their toxins with anticancer potential in human cell lines, generating promising results for future research toward controlling human adenocarcinomas. This review presents the knowledge that has evolved on the topic of toxins produced by cyanobacteria, ranging from their negative impacts to their benefits. Keywords: cyanobacteria; proliferation; cyanotoxins; toxicity; cancer 1. Introduction Cyanobacteria or blue green algae are prokaryote photosynthetic organisms and feature among the pioneering organisms of planet Earth.
    [Show full text]
  • Skin,Mucosal and Blood-Brain Barrier Kinetics
    FACULTY OF PHARMACEUTICAL SCIENCES DRUG Quality & Registration (DRUQUAR) Lab SKIN, MUCOSAL AND BLOOD-BRAIN BARRIER KINETICS OF MODEL CYCLIC DEPSIPEPTIDES: THE MYCOTOXINS BEAUVERICIN AND ENNIATINS Thesis submitted to obtain the degree of Doctor in Pharmaceutical Sciences Lien TAEVERNIER Promoter Prof. Dr. Bart DE SPIEGELEER FACULTY OF PHARMACEUTICAL SCIENCES Drug Quality & Registration (DruQuaR) Lab SKIN, MUCOSAL AND BLOOD-BRAIN BARRIER KINETICS OF MODEL CYCLIC DEPSIPEPTIDES: THE MYCOTOXINS BEAUVERICIN AND ENNIATINS Lien TAEVERNIER Master of Science in Drug Development Promoter Prof. Dr. Bart DE SPIEGELEER 2016 Thesis submitted to obtain the degree of Doctor in Pharmaceutical Sciences COPYRIGHT COPYRIGHT The author and the promotor give the authorization to consult and to copy parts of this thesis for personal use only. Any other use is limited by the Laws of Copyright, especially the obligation to refer to the source whenever results from this thesis are cited. Ghent, 9th of September 2016 The promoter The author Prof. Dr. Bart De Spiegeleer Lien Taevernier 3 ACKNOWLEDGEMENTS ACKNOWLEDGEMENTS I never could have achieved this work on my own, therefore I wish to thank some very important people and address a few words to them. I consider myself fortunate to know you and I was honoured to be able to work together with you and learn a great deal from all of you. First of all, a special thank you to my promoter Prof. Dr. Bart De Spiegeleer. I am grateful that you gave me the opportunity to pursue my Ph.D. at DruQuaR. Your door was always open for me, even if it did not consider work.
    [Show full text]
  • Hepatotoxic Cyanobacterial Blooms in Louisiana's Estuaries
    Louisiana State University LSU Digital Commons LSU Master's Theses Graduate School 2010 Hepatotoxic Cyanobacterial Blooms in Louisiana's Estuaries: Analysis of Risk to Blue Crab (Callinectes sapidus) Following Exposure to Microcystins Ana Cristina Garcia Louisiana State University and Agricultural and Mechanical College, [email protected] Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_theses Part of the Oceanography and Atmospheric Sciences and Meteorology Commons Recommended Citation Garcia, Ana Cristina, "Hepatotoxic Cyanobacterial Blooms in Louisiana's Estuaries: Analysis of Risk to Blue Crab (Callinectes sapidus) Following Exposure to Microcystins" (2010). LSU Master's Theses. 1132. https://digitalcommons.lsu.edu/gradschool_theses/1132 This Thesis is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in LSU Master's Theses by an authorized graduate school editor of LSU Digital Commons. For more information, please contact [email protected]. HEPATOTOXIC CYANOBACTERIAL BLOOMS IN LOUISIANA’S ESTUARIES: ANALYSIS OF RISK TO BLUE CRAB (CALLINECTES SAPIDUS) FOLLOWING EXPOSURE TO MICROCYSTINS A Thesis Submitted to the Graduate Faculty of the Louisiana State University and Agricultural and Mechanical College in partial fulfillment of the requirements for the degree of Master of Science in The Department of Oceanography and Coastal Sciences By Ana Cristina Garcia B.S. Louisiana State University, 2006 May 2010 ACKNOWLEDGEMENTS I would like to thank my major advisor Dr. Sibel Bargu. My experience at LSU as a graduate student has been invaluable under her guidance and support. Thanks to Dr. Bargu I have been provided with endless opportunities to explore the field of oceanography and limnology, for which I am forever grateful.
    [Show full text]
  • Bioassay Methods to Identify the Presence of Cyanotoxins in Drinking Water Supplies and Their Removal Strategies
    Available online a t www.pelagiaresearchlibrary.com Pelagia Research Library European Journal of Experimental Biology, 2012, 2 (2):321-336 ISSN: 2248 –9215 CODEN (USA): EJEBAU Bioassay methods to identify the presence of cyanotoxins in drinking water supplies and their removal strategies Monica Agrawal 1, Sulekha Yadav 1,2 , Chanda Patel 1,2 , Neelima Raipuria 1 and Manish K. Agrawal 2* 1M. H. College of Home Science and Science for Women, Napier Town, Jabalpur, India 2Daksh Laboratories, 1370, Home Science College Road, Napier Town, Jabalpur, India ______________________________________________________________________________ ABSTRACT A diversified group of toxins produced by freshwater cyanobacteria pose threat to human health as they frequently occur in drinking water sources. Though numerous qualitative as well as quantitative chemical analytical methods are now available, relatively simple low cost methods that are able to evaluate the potential health hazard and allow management decisions to be taken, are more useful to agencies that monitor drinking water supplies. Given that there is no single method that can provide adequate monitoring for all freshwater cyanotoxins in the increasing range of sample types, bioassays that can detect the toxic effects and safe levels of cyanobacterial toxins in drinking water supplies are discussed. Methods for removal of cyanobacterial cells as well as dissolved toxins in drinking waters prior to supply are also discussed. Key Words: Freshwater cyanobacteria, toxins, microcystins, bioassay, removal of toxins, waterworks. ______________________________________________________________________________ INTRODUCTION Most, though not all, cyanobacterial blooms and scums produce secondary metabolites that are toxic to aquatic animals, fishes, cattle and even human [1, 2, 3]. The most frequently found toxin producing cyanobacterial species in freshwaters are Microcystis, Anabaena, Nodularia, Planktothrix, Aphanizomenon, Cylindrospermopsin and Lyngbya etc.
    [Show full text]
  • Marine Cyanobacteria: a Source of Lead Compounds and Their Clinically-Relevant Molecular Targets
    molecules Review Marine Cyanobacteria: A Source of Lead Compounds and their Clinically-Relevant Molecular Targets Lik Tong Tan * and Ma Yadanar Phyo Natural Sciences and Science Education, National Institute of Education, Nanyang Technological University, Singapore 637616, Singapore; [email protected] * Correspondence: [email protected]; Tel.: +65-6790-3842 Academic Editor: Tatsufumi Okino Received: 25 March 2020; Accepted: 5 May 2020; Published: 8 May 2020 Abstract: The prokaryotic filamentous marine cyanobacteria are photosynthetic microbes that are found in diverse marine habitats, ranging from epiphytic to endolithic communities. Their successful colonization in nature is largely attributed to genetic diversity as well as the production of ecologically important natural products. These cyanobacterial natural products are also a source of potential drug leads for the development of therapeutic agents used in the treatment of diseases, such as cancer, parasitic infections and inflammation. Major sources of these biomedically important natural compounds are found predominately from marine cyanobacterial orders Oscillatoriales, Nostocales, Chroococcales and Synechococcales. Moreover, technological advances in genomic and metabolomics approaches, such as mass spectrometry and NMR spectroscopy, revealed that marine cyanobacteria are a treasure trove of structurally unique natural products. The high potency of a number of natural products are due to their specific interference with validated drug targets, such as proteasomes, proteases, histone deacetylases, microtubules, actin filaments and membrane receptors/channels. In this review, the chemistry and biology of selected potent cyanobacterial compounds as well as their synthetic analogues are presented based on their molecular targets. These molecules are discussed to reflect current research trends in drug discovery from marine cyanobacterial natural products.
    [Show full text]
  • Drug Development from Marine Natural Products
    REVIEWS Drug development from marine natural products Tadeusz F. Molinski*, Doralyn S. Dalisay*, Sarah L. Lievens*‡ and Jonel P. Saludes*‡ Abstract | Drug discovery from marine natural products has enjoyed a renaissance in the past few years. Ziconotide (Prialt; Elan Pharmaceuticals), a peptide originally discovered in a tropical cone snail, was the first marine-derived compound to be approved in the United States in December 2004 for the treatment of pain. Then, in October 2007, trabectedin (Yondelis; PharmaMar) became the first marine anticancer drug to be approved in the European Union. Here, we review the history of drug discovery from marine natural products, and by describing selected examples, we examine the factors that contribute to new discoveries and the difficulties associated with translating marine-derived compounds into clinical trials. Providing an outlook into the future, we also examine the advances that may further expand the promise of drugs from the sea. In 1967, a small symposium was held in Rhode Island, attracted some interested. Beginning in 1951, Werner USA, with the ambitious title “Drugs from the Sea”1. The Bergmann published three reports5–7 of unusual arabino- tone and theme of the meeting were somewhat hesitant, and ribo-pentosyl nucleosides obtained from marine even sceptical (one paper was entitled “Dregs [sic] from sponges collected in Florida, USA. The compounds the Sea”). The catchphrase of the symposium title has eventually led to the development of the chemical endured over the decades as a metaphor for drug develop- derivatives ara-A (vidarabine) and ara-C (cytarabine), ment from marine natural products, and in time genuine two nucleosides with significant anticancer properties drug discovery programmes quietly arose to fulfil that that have been in clinical use for decades.
    [Show full text]